Loading clinical trials...
Loading clinical trials...
This study aims to estimate the effect of the practice of a short-term partial fasting compared to a usual alimentation on nausea and vomiting within 5 days after the start of a chemotherapy session o...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Centre Hospitalier Universitaire de la Réunion
NCT06120764 · Chemotherapy-induced Nausea and Vomiting, Pediatric Cancer
NCT07540169 · Stomach Cancer, Chemotherapy-induced Nausea and Vomiting, and more
NCT07446439 · Nausea and Vomiting, Obesity
NCT07537673 · Nausea and Vomiting Caused by Trastuzumab Deruxtecan
NCT07537660 · Nausea and Vomiting Caused by Chemotherapy
CHU de la Réunion
Saint-Pierre
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions